Medicine guide

Retsevmo 80 mg

As listed in the register: Retsevmo 80 mg, gélules

80 mg ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Selpercatinibum
Made by
Eli Lilly (Suisse) SA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • RET-fusionspositives nicht-kleinzelliges Lungenkarzinom (NSCLC), RET-fusionspositives Schilddrüsenkarzinom, RET-mutantes medulläres Schilddrüsenkarzinom

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byEli Lilly (Suisse) SA
Active substanceSelpercatinibum
Used inCancer treatments and immune-system medicines
Strength80 mg
ClassificationL01EX22 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerRetsevmo 80 mg, gélules
Packs56 Kapsel(n) · 112 Kapsel(n)
Zulassungsnummer67862
Dosisstärke2

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.